Malaria Vaccine Breakthrough

A newly licensed malaria vaccine shows promise with a 30% efficacy rate, which, while lower than some COVID vaccines, could significantly impact malaria transmission. The vaccine targets children and aims to disrupt the complex human-mosquito cycle of the parasite. By preventing infection and subsequent transmission, it represents a crucial step in combating this deadly disease.